BCPC Stock Overview
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally.
No risks detected for BCPC from our risk checks.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$126.89|
|52 Week High||US$174.29|
|52 Week Low||US$114.79|
|1 Month Change||-0.55%|
|3 Month Change||-10.03%|
|1 Year Change||-3.14%|
|3 Year Change||39.92%|
|5 Year Change||53.10%|
|Change since IPO||80,198.44%|
Recent News & Updates
Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price
Today we will run through one way of estimating the intrinsic value of Balchem Corporation ( NASDAQ:BCPC ) by...
Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
|BCPC||US Chemicals||US Market|
Return vs Industry: BCPC underperformed the US Chemicals industry which returned 0.2% over the past year.
Return vs Market: BCPC exceeded the US Market which returned -10.2% over the past year.
|BCPC Average Weekly Movement||3.7%|
|Chemicals Industry Average Movement||7.1%|
|Market Average Movement||7.8%|
|10% most volatile stocks in US Market||17.0%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: BCPC is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: BCPC's weekly volatility (4%) has been stable over the past year.
About the Company
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Balchem Fundamentals Summary
|BCPC fundamental statistics|
Is BCPC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BCPC income statement (TTM)|
|Cost of Revenue||US$586.28m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||3.16|
|Net Profit Margin||12.07%|
How did BCPC perform over the long term?See historical performance and comparison
0.5%Current Dividend Yield
Is Balchem undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: BCPC ($126.89) is trading above our estimate of fair value ($99.46)
Significantly Below Fair Value: BCPC is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: BCPC is poor value based on its Price-To-Earnings Ratio (40.1x) compared to the US Chemicals industry average (17.2x).
PE vs Market: BCPC is poor value based on its Price-To-Earnings Ratio (40.1x) compared to the US market (15.6x).
Price to Earnings Growth Ratio
PEG Ratio: BCPC is poor value based on its PEG Ratio (3.7x)
Price to Book Ratio
PB vs Industry: BCPC is overvalued based on its Price-To-Book Ratio (4.7x) compared to the US Chemicals industry average (2.3x).
How is Balchem forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BCPC's forecast earnings growth (10.9% per year) is above the savings rate (1.9%).
Earnings vs Market: BCPC's earnings (10.9% per year) are forecast to grow slower than the US market (13.2% per year).
High Growth Earnings: BCPC's earnings are forecast to grow, but not significantly.
Revenue vs Market: BCPC's revenue (6.2% per year) is forecast to grow slower than the US market (8.1% per year).
High Growth Revenue: BCPC's revenue (6.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BCPC's Return on Equity is forecast to be high in 3 years time
How has Balchem performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BCPC has high quality earnings.
Growing Profit Margin: BCPC's current net profit margins (12.1%) are lower than last year (12.3%).
Past Earnings Growth Analysis
Earnings Trend: BCPC's earnings have grown by 5% per year over the past 5 years.
Accelerating Growth: BCPC's earnings growth over the past year (15.1%) exceeds its 5-year average (5% per year).
Earnings vs Industry: BCPC earnings growth over the past year (15.1%) underperformed the Chemicals industry 28.9%.
Return on Equity
High ROE: BCPC's Return on Equity (11.6%) is considered low.
How is Balchem's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: BCPC's short term assets ($319.8M) exceed its short term liabilities ($123.5M).
Long Term Liabilities: BCPC's short term assets ($319.8M) exceed its long term liabilities ($197.7M).
Debt to Equity History and Analysis
Debt Level: BCPC's net debt to equity ratio (7.3%) is considered satisfactory.
Reducing Debt: BCPC's debt to equity ratio has reduced from 49.6% to 14.7% over the past 5 years.
Debt Coverage: BCPC's debt is well covered by operating cash flow (98.7%).
Interest Coverage: BCPC's interest payments on its debt are well covered by EBIT (59.6x coverage).
What is Balchem current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: BCPC's dividend (0.51%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.49%).
High Dividend: BCPC's dividend (0.51%) is low compared to the top 25% of dividend payers in the US market (3.92%).
Stability and Growth of Payments
Stable Dividend: BCPC is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: BCPC is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: BCPC is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: BCPC is not paying a notable dividend for the US market.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ted Harris (56 yo)
Mr. Theodore L. Harris, also known as Ted, has been the Chief Executive Officer and President at Balchem Corporation since April 28, 2015. He serves as an Independent Director of Pentair Plc since April 30...
CEO Compensation Analysis
Compensation vs Market: Ted's total compensation ($USD5.76M) is about average for companies of similar size in the US market ($USD6.55M).
Compensation vs Earnings: Ted's compensation has increased by more than 20% in the past year.
Experienced Management: BCPC's management team is considered experienced (4 years average tenure).
Experienced Board: BCPC's board of directors are considered experienced (6.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Balchem Corporation's employee growth, exchange listings and data sources
- Name: Balchem Corporation
- Ticker: BCPC
- Exchange: NasdaqGS
- Founded: 1967
- Industry: Specialty Chemicals
- Sector: Materials
- Implied Market Cap: US$4.075b
- Shares outstanding: 32.12m
- Website: https://www.balchem.com
Number of Employees
- Balchem Corporation
- 52 Sunrise Park Road
- New Hampton
- New York
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/28 00:00|
|End of Day Share Price||2022/05/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.